INTRODUCTION
Pheochromocytoma (PHEO) is a tumor derived from chromaffin cells of the sympathetic nervous system and its clinical symptoms are associated with excessive production and release of catecholamines which can cause arterial hypertension and symptoms attributed to paroxysmal stimulation of the adrenergic 1, 2 Since the first report on laparoscopic adrenalectomy by Gagner in 1992, this approach has increasingly become the gold standard for excision of benign functioning and non-functioning tumors of the adrenal 3 Laparoscopic adrenalectomy compared to traditional open resection has proven equally safe and efficient, offering a number of significant advantages such as improved access to the surgical area, less blood loss, decreased requirement for postoperative analgesia, shorter hospital stay and earlier return to [4] [5] [6] On the other hand, in large PHEOs technical difficulties increase due to possible hemodynamic inGiven the technical challenges for resection of large PHEOs, there were hesitations about using a laparoscopic approach for these tumors during the first improvement in imaging modalities, better pharmacological preparation, advances in anaesthesia and laparoscopic surgery as well as evolving technology rendered laparoscopic surgery for PHEO safe and 7
MATERIALS AND METHODS
A total of 68 procedures for PHEO were performed paragangliomas operated on during the same period -agnosis, operative details, complications, length of hospital stay, morbidity and follow-up were retrieved from the hospital records of 533 patients who underwent 541 adrenalectomies for benign and malignant have been retrieved from our Department database One patient with MEN2A syndrome underwent bilateral tumor resection with left cortex-preserving Preoperative localization was established in all patients by computerized tomography (CT) or magnetic resonance imaging (MRI), while iodine-123 metaiodobenzylguanidine (MIBG) scan was reserved for ambiguous cases where paraganglioma or metastatic according to an established protocol drawn up by the Department of Endocrinology and Diabetes Center Endocrinological evaluation and complete adrenal dynamic testing were performed to determine whether basal adrenal hormonal investigation including serum cortisol, adrenocorticotropin (ACTH), dehydroepiandrosteronesulphate, renin and aldosterone levels, and hypersecretion included 24-h urinary free cortisol and measurement of serum cortisol and ACTH levels after an overnight dexamethasone suppression test (1mg of dexamethasone administrated at midnight, before included the measurement of urinary fractioned metanephrines (normetanephrines and metanephrines) as of plasma free or urinary fractionated metanephrines are superior to other tests of catecholamine excess for the diagnosis of pheochromocytomas 8 and, until there are data directly comparing plasma and urinary measurements, there is no recommendation that one dose of phenoxybenzamine (starting dose 10mg -mean dose 100mg -max dose 200mg) was administered for 7-14 days prior to surgery to achieve a blood pressure intravenous fluids were administered after the second or third day of the initiation of medical treatment in order to achieve volume expansion and counteract the All patients had blood pressure less than 140/80mm Hg, to omit orthostatic hypotension not exceeding 80/45mmHg, no more than one ventricular extrasystole every 5 minutes and ECG without nonspecific ST segment elevations or depression as well as T wave inversions, thus ensuring adequate preopera- nitroprusside has a rapid onset of action but also end/ termination of effect and should only be administered with the same protocol of phenoxybenzamine titration Transient episodes of arrhythmia or tachycardia (duration <30s) were not documented as part of the study protocol and no sustained episodes (duration >30s) of abnormal cardiac rhythm or frequency were with a negative preoperative work-up for PHEO and therefore no blockade, who presented hemodynamic instability during the operation and finally proved to have a potentially malignant PHEO with a PASS = 6 Postoperatively, there were no life-threatening complications, except for one patient who after right laparoscopic adrenalectomy developed pulmonary All patients showed remarkable improvements in hypertension and reversal of the characteristic symptoms of constant adrenoreceptor stimulation
No clinically significant episodes of postoperative At a mean follow-up interval of 152 months after years), resolution of hormonal activity and no evipatient with the recurrent malignant PHEO survived with potentially malignant features on pathology as assessed by PASS were identified, but follow-up has not demonstrated thus far any evidence of recurrence
DISCUSSION
We reviewed our experience with operative treatment of pheochromocytoma to demonstrate the safety and efficacy of the laparoscopic approach and to present some noteworthy issues concerning the management adrenergic blockade, morbidity and mortality associated with hemodynamic lability due to excessive -erative mortality in the pre-blockade era was reported 15 Preoperative blockade has significantly reduced adverse outcomes but has not completely eliminated episodes of hemodynamic 16 Proper preparation of the patient before surgery - 28, 33 This is probably the result of direct tumor compres-
28
Early ligation of the adrenal vein has historically been suggested as a prophylactic factor minimizing 34 By contrast, others endorse the safety of delayed adrenal vein ligation, challenging that laparoscopic adrenalectomy of large PHEOs is safe as long as the surgeon has the appropriate experi-43 When using 4 cm as a cut-off value between small and large tumors there does not seem to be a significant difference in operative time and surgical 44 In light of this, laparoscopic adrenalectomies have been performed for non-PHEO tumors up to 15 cm in diameter without any significant morbidity, therefore PHEO size does not seem to preclude [45] [46] [47] [48] [49] Suspected malignancy remains a controversial is-50 Thus far, the only universally accepted criterion 9 Currently there is no definitive way to predict which metastases it is impossible to precisely evaluate the degree of malignancy based on biochemical and 51 most popular scale employed for estimating the risk of malignancy is the PASS, which was developed 51, 52 Thompson proposed that been demonstrated that this system cannot precisely the importance of the long-standing tradition of early 35, 36 In our opinion, this technique may be even safer because the tumor is mobilized from the inferior vena cava to the right and the renal vein to the left and thus posNonetheless, we always contemplate an initial effort to dissect the main adrenal vein at an early stage of the procedure but, if safety is jeopardized, we follow 37 Tumor size is another consideration in laparoguidelines published by the Endocrine Society suggest open adrenalectomy as the treatment modality of choice in PHEOs larger than 6 cm due to increased concerns for obtaining safe oncological margins and 38 A recent limited non-randomized controlled study of large pheochromocytomas (>6 cm) comparing laparascopic adrenalectomy and open adrenalectomy indicated that recurrence rates were not statistically different between the two groups, thus questioning 39 However, sample sizes were relatively small and larger studies are required to fully validate laparoscopic adrenalectomy in large has not been conclusively proven to be a reliable predictor of recurrence or malignant potential, with 10, 40 In our study the largest PHEO excised laparoscopito an open procedure because of periadrenal tumor -rence or metastasis can develop as long as 20 years after surgical excision and therefore all patients need Tumor size may also be a concern regarding convercommon incidental cause of conversion in adrenal- 14, 41, 42 As previously mentioned, PHEOs are characterized by a rich network of vessels and thus carry a higher probability of intraoperative troublesome hemorrage open procedure for successful hemostasis in patients PHEOs exhibit a modest response to radiotherapy 54 Surgical resection 55 However, there are concerns about the ability of minimally invasive techniques to totally remove the malignant lesion and avoid capsular disruption of the tumor potentially malignant (or locally aggressive) PHEOs can be performed in appropriately selected cases, in experienced centers with oncologic outcomes that are equivalent to open approaches, while providing 56 Proponents of minimally invasive techniques argue that in the hands of experienced surgeons, laparoscopy can be safely performed while preserving the principles of oncologic surgery, with results similar to those are to avoid direct manipulation of or application of pressure to the tumor in order to avoid rupture of 51, 57 The adrenal gland is resected en bloc with the surrounding adipose tissue and it is always extracted after being placed in a specimen 51 PHEO has been proposed as an independent fac-14 In our series our the laparoscopic approach for other benign adrenal 61 However, after the eighth laparoscopic attempt conversion rates dropped significantly the intricacies of this procedure have a profound effect on successful completion by laparoscopy and might indicate different learning curves compared to other conversation rate, no statistical significance is noted conversion rates may be partially explained by the low threshold to convert to an open procedure during the first attempts rather than struggle to complete a laparoscopic operation by risking disruption of the 
